Llwytho...
Bortezomib-based Regimens Improve the Outcome of Patients with Primary or Secondary Plasma Cell Leukemia: A Retrospective Cohort Study
OBJECTIVE: The management experience for plasma cell leukemia (PCL) is still limited by PCL’s rare incidence and aggressive course. The goal of this study was to further identify the efficacy of bortezomib-containing regimens for PCL in Chinese patients. MATERIALS AND METHODS: In this study, 56 cons...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Turk J Haematol |
|---|---|
| Prif Awduron: | , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Galenos Publishing
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7236418/ https://ncbi.nlm.nih.gov/pubmed/31769277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4274/tjh.galenos.2019.2019.0254 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|